Agenda Clinical Hematology & Oncology 2023
Saturday, February 18, 2023
7 a.m.
Registration, Breakfast & View Exhibits
Non-CME Breakfast Symposium Hosted by AbbVie
Pivotal Phase 3 Data in Newly Diagnosed AML
Jamie Koprivnikar, MD
TOPIC: NON-MALIGNANT HEMATOLOGY
Moderator: Emily Nagler, MD
7:55 a.m.
Welcome & Announcements
Michael P. Kosty, MD
8 a.m.
ITP: What Has Changed and What Has Not
John Kelton, MD
8:30 a.m.
Bleeding and Clotting Side Effects of Drugs Used by the Oncologist
Allison Burnett, PharmD
9 a.m.
Approach to Bleeding of Unknown Cause
Ming Lim, MBBCH, MS
9:30 a.m.
Panel Discussion/Q&A
Allison Burnett, PharmD, John Kelton, MD and Ming Lim, MBBCH, MS
10 a.m.
Break & View Exhibits
10:30 a.m.
Robert L. Longmire Lectureship
Thrombosis and Anticoagulation: 2023 Update
Stephan Moll, MD
11 a.m.
Hereditary Hemorrhagic Telangiectasia: 2023 Update
Raj Kasthuri, MBBS
11:30 a.m.
Sickle Cell Disease: 2023 Update
Samuel Wilson, MD
Noon
Panel Discussion/Q&A
Raj Kasthuri, MBBS, Stephan Moll, MD, and Samuel Wilson, MD
12:30 p.m.
Lunch
Non-CME Lunch Symposium Hosted by Pfizer
A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation
Anne O’Dea, MD
TOPIC: HEMATOLOGY & MALIGNANT HEMATOLOGY
Moderator: David Hermel, MD
1:30 p.m.
Outpatient DVT Prophylaxis in Oncology Patients: Who Should Get It and How Are We Doing In Our Practices?
Karlyn Martin, MD
2 p.m.
Best Frontline Treatment of CLL
Susan O’Brien, MD
2:30 p.m.
DLBCL – Will Bispecific Antibodies Compete with CAR-T?
Jeremy Abramson, MD
3 p.m.
Panel Discussion/Q&A
Jeremy Abramson, MD, Karlyn Martin, MD, and Susan O’Brien, MD
3:30 p.m.
Break & View Exhibits
3:45 p.m.
Chemo and Non-Chemotherapy Options for Patients with Waldenstrom's Macroglobulinemia
Morie Gertz, MD
4:15 p.m.
Immunological Treatment Advances in Hodgkin Disease
Ranjana Advani, MD
4:45 p.m.
Chemotherapy-Free Treatment of Ph(+) ALL
Nicholas Short, MD
5:15 p.m.
Panel Discussion/Q&A
Ranjana Advani, MD, Morie Gertz, MD, and Nicholas Short, MD
5:45 p.m.
Adjourn
5:45 p.m.
Welcome Reception
6 p.m.
Non-CME Dinner Symposium Hosted by Exelixis
Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer
Munveer Bhangoo, MD
Sunday, February 19, 2023
7 a.m.
Breakfast & View Exhibits
Non-CME Breakfast Symposium Hosted by Seagen
A Review of Evidence-Based Data for an Antibody-Drug Conjugate for la/MUC
Przemyslaw Twardowski, MD
TOPIC: ONCOLOGY
Moderator: Kathryn Bollin, MD
7:55 a.m.
Welcome & Announcements
Michael P. Kosty, MD
8 a.m.
Bernard L. Schwartz Lectureship
Update on Management of Patients with Myeloproliferative Disorders
Ayalew Tefferi, MD
8:30 a.m.
Chemo and Non-Chemotherapy Treatment of Mantle Cell Lymphoma
Michael Wang, MD
9 a.m.
Novel Strategies in the Management of Brain Metastasis
Isabella Glitza, MD
9:30 a.m.
Panel Discussion/Q&A
Isabella Glitza, MD, Ayalew Tefferi, MD, and Michael Wang, MD
10 a.m.
Break & View Exhibits
10:30 a.m.
Approaches to the Patient with Metastatic Urothelial Cancer
Jean Hoffman-Censits, MD
11 a.m.
The Role of Immunotherapy and Targeted Therapy in GYN Cancers
Stephanie Gaillard, MD
11:30 a.m.
Clinical Role of ctDNA Assays in Decision-making for Colorectal Cancer Adjuvant Therapy
Stacey Cohen, MD
Noon
Panel Discussion/Q&A
Stacey Cohen, MD, Stephanie Gaillard, MD, and Jean Hoffman-Censits, MD
12:30 p.m.
Lunch
Non-CME Lunch Symposium Hosted by Genentech
Evolving CLL Treatment Paradigms Exploring Chemo Free Regimens With A Fixed Treatment Duration
Catherine Coombs, MD
Non-CME Lunch Symposium Hosted by Bristol Myers Squibb
Hematologist & Oncologist Perspectives on Properly Diagnosing, Classifying, and Managing Low-Risk Myelodysplastic Syndromes
David Hermel, MD & Marin Xavier, MD
TOPIC: ONCOLOGY
Moderator: Aditya Sarvaria, MD
1:30 p.m.
Approaches to Metastatic Castration Sensitive Prostate Cancer – Patient and Regimen Selection
Sandy Srinivas, MD
2 p.m.
When Patients Progress: Treating Progressive NSCLC
Vamsidhar Velcheti, MD
2:30 p.m.
Newer Immunotherapeutic Options for Metastatic Melanoma
April Salama, MD
3 p.m.
Panel Discussion/Q&A
April Salama, MD, Sandy Srinivas, MD, and Vamsidhar Velcheti, MD
3:30 p.m.
Break & View Exhibits
CONCURRENT BREAKOUT SESSIONS
4 p.m.
Breakout #1: Clinical Case Studies in Thrombosis
Raj Kasthuri, MBBS
Breakout #2: Clinical Case Studies of Clotting Disorders in High-Level Athletes and Other Patients Engaged in Sports
Stephan Moll, MD
Breakout #3: Clinical Case Studies in Hemoglobinopathies
Samuel Wilson, MD
Breakout #4: Clinical Case Studies in Refractory Clotting Disorders
Karlyn Martin, MD
5 p.m.
Adjourn
5:30 p.m.
Non-CME Dinner Symposium Hosted by Beigene
Brukinsa (Zanubrutinib) for Adult Patients With CLL/SLL
Herbert Eradat, MD
Monday, February 20, 2023
7 a.m.
Breakfast & View Exhibits
Non-CME Breakfast Symposium Hosted by Genentech
LUNSUMIO™ (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular Lymphoma
Enrique Diaz, MD
Non-CME Breakfast Symposium Hosted by Astellas Pharma & Pfizer
Elevate Care in Advanced Prostate Cancer
Przemyslaw Twardowski, MD
TOPIC: BREAST CANCER
Moderator: Farah Nasraty, MD
7:55 a.m.
Welcome & Announcements
Michael P. Kosty, MD
8 a.m.
Redefining Triple Negative Breast Cancer
Heather McArthur, MD
8:30 a.m.
Optimal Duration of Endocrine Therapy
Virginia Kaklamani, MD
9 a.m.
Treatment of the Axilla in Early Breast Cancer
Mehra Golshan, MD
9:30 a.m.
Panel Discussion/Q&A
Mehra Golshan, MD, Virginia Kaklamani, MD, and Heather McArthur, MD
10 a.m.
Break & View Exhibits
10:30 a.m.
How to Manage Patients with Small HER-2 (+) Tumors
Mothaffar Rimawi, MD
11 a.m.
Future of ADC Therapy of Breast Cancer
Hope Rugo, MD
11:30 a.m.
Practical Management of AI-related Side-Effects
Mohammed Jaloudi, MD
Noon
Panel Discussion/Q&A
Mohammed Jaloudi, MD, Mothaffar Rimawi, MD, and Hope Rugo, MD
12:30 p.m.
Final Adjournment
Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.